March 2025 | Report Format: Electronic (PDF)
Animal Health Market Growth & Trends
The global animal health market size is expected to reach USD 112.33 billion by 2030, registering a CAGR of 10.46% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increased investments in animal health, product approvals, diagnostic rates, initiatives by key companies, and increased animal health expenditure. The market has also remained largely resilient during the COVID-19 pandemic. In November 2023, MSD Animal Health received European Commission approval for BOVILIS CRYPTIUM- a vaccine to protect cattle against Cryptosporidium parvum (C. parvum) infection. This enabled the company to commercialize the product across all European Union countries.
The threat of zoonotic infections spreading through ticks, and fleas or through contact with animals is high. The WHO is involved in various cross-sectoral activities for the purpose of addressing health threats at the human-animal-ecosystem interface. Food-borne zoonoses, antimicrobial resistance, and emerging zoonoses are some of the threats in the animal health market. Also, MediLabSecure, a laboratory network project, was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean region. The implementation of a wide range of technologies for the detection and monitoring of various animal diseases is one of the major growth contributing factors.
Key market participants employ various strategies, such as expanding their product portfolio, to gain a competitive advantage. For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for poultry to protect against Infectious Bursal Disease (IBD). This added to Zoetis’ product portfolio of recombinant vector vaccines. The market especially for the companion animal segment was positively impacted during late 2020 and 2021, due to increased pet adoption rates, pet humanization trends, and improved overall diagnostics business sales with increased awareness among pet parents. During 2022 and 2023 however, macroeconomic uncertainties, such as global recession and inflation, notably impacted market revenues for a short period.
Request a free sample copy or view report summary:
Animal Health Market Report
Animal Health Market Report Highlights
- Based on products, the pharmaceutical segment dominated the market with a share of about 43.42% in 2024. It is estimated to retain its dominant position throughout the forecast period due to consistent advancements in veterinary drugs.
- In 2024, the production animal segment dominated the market and accounted for the largest revenue share. The substantial segment share results from increased concern for food safety and sustainability among end users as well as market stakeholders such as government healthcare organizations.
- The hospital/clinic pharmacy segment accounted for the largest revenue share in 2024 in terms of distribution channels. The increasing number of hospital pharmacies and high procedural volume have supported segment growth.
- By end-use, the veterinary hospitals and clinics segment accounted for the largest revenue share of the market in 2024. This is due to a large number of hospitals and clinics across the globe and highest footfall of patients at these care centers.
- North America animal health market held the highest share of about 35.69% in 2024. The dominant share can be attributed to the high prevalence of livestock and zoonotic diseases leading to large-scale animal deaths.
Animal Health Market Segmentation
Grand View Research has segmented the global animal health market on the basis of on product, animal type, distribution channel, end-use and region:
Animal Health Type Outlook (Revenue, USD Million, 2018–2030)
- Production Animals
- Poultry
- Swine
- Cattle
- Sheep & Goats
- Fish
- Companion Animals
- Dogs
- Cats
- Horses
- Others
Animal Health Product Outlook (Revenue, USD Million, 2018–2030)
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Medicinal Feed Additives
- Diagnostics
- Consumables, reagents and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
Animal Health Distribution Channel Outlook (Revenue, USD Million, 2018–2030)
- Retail
- E-Commerce
- Hospital/ Clinic Pharmacy
Animal Health End-use Outlook (Revenue, USD Million, 2018–2030)
- Veterinary Reference Laboratories
- Point-of-care Testing/In-house Testing
- Veterinary Hospitals & Clinics
- Others
Animal Health Regional Outlook (Revenue, USD Million, 2018–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Sweden
- Denmark
- Norway
- Russia
- Ireland
- Poland
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Indonesia
- Thailand
- Australia
- South Korea
- Philippines
- Malaysia
- Singapore
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- UAE
- Kuwait
- Egypt
- Iran
- Israel
- Rest of MEA
List of Key Players in the Animal Health Market
- Zoetis
- Ceva Santé Animale
- Merck & Co., Inc.
- Vetoquinol S.A.
- Boehringer Ingelheim Gmbh
- Elanco
- Virbac
- Mars Inc.
- Dechra Pharmaceuticals Plc
- Idexx Laboratories, Inc.
